水溶性柱[6]に基づくpH反応性超分子ベジクルは,薬剤投与のためのアレンとフェロセンの誘導体である
1Key Laboratory of Mesoscopic Chemistry of MOE, Center for Multimolecular Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China.
Journal of the American Chemical Society
|June 26, 2013
まとめ
ホスト・ゲスト複合体から自己組み立てられた新型超分子膀は,pH反応薬の投与を可能にします. これらの膀は,がん細胞にミトキサントロン (MTZ) を効率的に負荷して放出し,抗がん効果を維持しながら毒性を軽減します.
科学分野:
- 超分子化学とは
- マテリアルサイエンス 材料科学
- ナノテクノロジー ナノテクノロジー
背景:
- 先進的な薬物投与システムの開発は,治療効果の向上と副作用の軽減に不可欠です.
- 超分子自己組み立ては,機能的なナノ構造を作り出すための汎用的なプラットフォームを提供します.
- 特定の生理学的環境における標的の薬物放出のために,pH反応性のある材料が望ましい.
研究 の 目的:
- ホスト・ゲスト・インクルージョン・コンプレックスを用いた新しい超分子薬物投与システムを開発する.
- セルフ・アセンブリされた膀のpH反応的行動と薬物放出特性を調査する.
- 薬剤を注入した膀の細胞吸収,毒性,および抗がん効果を評価する.
主な方法:
- 水溶性柱[6]アレン (WP6) とフェロセンの誘導体である宿主-ゲスト複合体から超分子胞の自己組み立て.
- NMR,UV-vis,および光スペクトロスコピーを用いて複合性の特徴付け.
- DLS,TEM,および光探査技術による膀特性およびpH反応性の調査.
- ミトキサントロン (MTZ) を用いた試験室内薬物負荷および放出試験.
- 細胞吸収と細胞毒性アッセイは,生細胞画像と標準的な細胞毒性試験を使用して行われます.
主要な成果:
- 高結合 afinity (1.27 × 10^5 M^-1) と 1:1 ステキオメトリを持つ安定したホスト-ゲストインクルージョン複合体が形成されました.
- 含有複合体は,水溶液中のpH反応性超分子ベジクルに自己組み立てました.
- 膀はミトキサントロン (MTZ) を効果的に封じ込み,酸性条件下での急速な放出を示した.
- MTZを搭載した膀は,がん細胞による細胞吸収が顕著であり,正常細胞に対する毒性が低下しました.
- MTZを積んだ膀は, in vitroでは,フリーMTZと比較可能な抗がん活性を示した.
結論:
- WP6-フェロセンの宿主-ゲスト複合体に基づいて,新しい,pH反応性の超分子膀系が成功裏に開発されました.
- このシステムは,効率的な薬物の負荷,制御された放出,および全身的毒性の減少を示しています.
- これらの超分子胞は,がん治療の有効で安全な薬物投与プラットフォームとして大きな可能性を秘めています.
関連する概念動画
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...

